Resource Type

Journal Article 2

Year

2022 2

Keywords

Fc fragment of the IgG-binding protein 1

cabozantinib 1

children 1

hepatocellular carcinoma 1

mechanistic target of rapamycin kinase inhibitor 1

primary resistance 1

proteomics 1

rapamycin 1

severe Mycoplasma pneumoniae pneumonia 1

open ︾

Search scope:

排序： Display mode:

Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular

Frontiers of Medicine 2022, Volume 16, Issue 3,   Pages 467-482 doi: 10.1007/s11684-021-0869-y

Abstract: primary resistance to cMet inhibitors, and the combination of cabozantinib and mammalian target of rapamycin(mTOR) inhibitor, rapamycin, exhibited a synergistic inhibitory effect on the in vitro cell proliferationMechanically, the combination of rapamycin with cabozantinib resulted in the remarkable inhibition ofMeanwhile, rapamycin enhanced the inhibitory effects of cabozantinib on the migration and tubule formationIn conclusion, our findings uncover a potential combination therapy of cabozantinib and rapamycin to

Keywords： hepatocellular carcinoma     cabozantinib     primary resistance     rapamycin    

HTML PDF Collect

Proteomics study of Mycoplasma pneumoniae pneumonia reveals the Fc fragment of the IgG-binding protein as a serum biomarker and implicates potential therapeutic targets

Frontiers of Medicine 2022, Volume 16, Issue 3,   Pages 378-388 doi: 10.1007/s11684-021-0840-y

Abstract: Among them, a mechanistic target of rapamycin kinase (mTOR) inhibitor, which is a macrolide compound

Keywords： pneumonia     children     proteomics     Fc fragment of the IgG-binding protein     mechanistic target of rapamycin    

HTML PDF Collect

Title Author Date Type Operation

Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular

Journal Article

Proteomics study of Mycoplasma pneumoniae pneumonia reveals the Fc fragment of the IgG-binding protein as a serum biomarker and implicates potential therapeutic targets

Journal Article